• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- COVID and flu markers continue downward trends

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/covid-19/covid-and-flu-markers-continue-downward-trends

COVID and flu markers continue downward trends


Lisa Schnirring

53 minutes ago.

COVID-19
After a modest holiday bump for COVID-19 and an early surge for flu, levels of both illnesses continue to fall, the Centers for Disease Control and Prevention (CDC) said today in separate reports.

XBB.1.5 proportions rise in all regions

Proportions of the more transmissible Omicron XBB.1.5 subvariant continue to rise, and the CDC estimates that it now makes up 66.4% of new cases, up from about 60% the previous week. The proportion of XBB.1.5 is rising in all parts of the country but is dominant across the eastern seaboard and in the south.

All other Omicron lineages are declining, including CH.1, which appears to be partly fueling upward COVID-19 levels in the United Kingdom.

In its weekly snapshot of COVID-19 data, the CDC said the 7-day average for new daily cases is 40,130, down 6.7% compared to a week ago. The weekly averages also show an 8.4% decrease in hospitalizations. The nation is averaging 493 deaths a day, down 9% from a week ago.

One marker that rose was polymerase chain reaction (PCR) test positivity, which was up compared to the week before and is at 11%.

In other US COVID developments, the Food and Drug Administration (FDA) on Feb 1 announced that it revised the emergency use authorizations for the two oral antivirals treatments—Paxlovid and Lagevrio—to remove the requirement for a positive COVID-19 test before prescribing.

Flu continues steady decline

In its latest weekly flu update today, the CDC said most indicators fell, except for the percentage of outpatient visits for flulike illness, which for the second week in a row remained at 2.6%, just a hair above the national baseline.

Only four jurisdictions reported very high or high flu activity, a marker that also reflects doctor visits for flu. Oklahoma is still reporting very high activity. Meanwhile, New Mexico, New York City, and Puerto Rico are still reporting high flu activity.

Influenza A made up 99.4% of samples that tested positive at public health labs. Of subtyped influenza A viruses, 62.4% were H3N2, and 37.6% were 2009 H1N1.

Hospitalizations for flu and flu activity at long-term care facilities also declined last week.

Six more pediatric flu deaths were reported, bringing the season's total to 97. The latest deaths all occurred over the first 3 weeks of January. All involved influenza A, and of four subtyped viruses, two were 2009 H1N1, and two were H3N2.
 
Back
Top Bottom